Overview
Now in its 44th year, the Chemotherapy Foundation Symposium (CFS®) brings together thousands of health care professionals for an exciting 3-day conference that promotes the delivery of evidence-based, state-of-the-art cancer care. Internationally renowned faculty will provide you with expert insights on the latest developments in cancer therapeutics, offering a unique opportunity to learn how innovative approaches fit into existing treatment paradigms to optimize clinical care for your patients with cancer.
Exciting new developments and rapid changes continue to occur in the management of solid and hematologic malignancies. In the past year, practice-changing diagnostic, therapeutic, and supportive care strategies have entered clinical practice, and many more are poised to do so. Optimized testing and treatments for early and advanced disease, including chemotherapeutics, targeted therapies, immunotherapies—alone and in combination—and multimodal strategies continue to improve clinical outcomes. CFS® offers you the critical knowledge you need to safely and effectively integrate these strategies into your practice.
Program Co-Chairs
Benjamin P. Levy, MD |
John O. Mascarenhas, MD |
Tiffany A. Traina, MD, FASCO |
To view full profile, click on the Program Co-Chairs tab above.